{"company":{"id":3783003,"name":"AirNexis","domain":"airnexis.com","url":"https://alion.io/company/world-13"},"section":"news","answer":"AirNexis: 11 headlines on record, 1 headline in the last 90 days.","figures":[{"label":"Headlines","value":"11"},{"label":"In 90 days","value":"1"},{"label":"Milestones","value":"0"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":10}],"news":[{"date":"2026-09-08","kind":"Blog","title":"AirNexis Announces that AN01 Met its Primary Endpoint in a Phase 2b COPD Study","url":"https://airnexis.com/news/airnexis-announces-that-an01-met-its-primary-endpoint-in-a-phase-2b-copd-study/"},{"date":"2026-01-12","kind":"News","title":"海思科：与美国AirNexis公司签订独占许可协议最高可获9.55亿美元里程碑付款_腾讯新闻","source":"news.qq.com","url":"https://news.qq.com/rain/a/20260112A035KH00"},{"date":"2026-01-11","kind":"News","title":"AirNexis Therapeutics Launches With $200 Million Series A To Advance Phase 2 Dual PDE3/4 Inhibitor AN01 For COPD","source":"Pulse 2.0","url":"https://pulse2.com/airnexis-therapeutics-200-million-series-a/"},{"date":"2026-01-10","kind":"News","title":"超10亿美元海思科与AirNexis签订独占许可协议","source":"finance.sina.com.cn","url":"https://finance.sina.com.cn/jjxw/2026-01-10/doc-inhfuvqu9714454.shtml"},{"date":"2026-01-09","kind":"News","title":"海思科：与AirNexis签署HSK39004项目授权许可协议_腾讯新闻","source":"news.qq.com","url":"https://news.qq.com/rain/a/20260109A06YN700?id=20260109A06YN700&amp;path=a&amp;app=news&amp;suid=&amp;redirect_pc=1"},{"date":"2026-01-09","kind":"Press release","title":"AirNexis Launches with $200 Million Series A to Advance AN01","url":"https://airnexis.com/news/airnexis-launches-series-a/"},{"date":"2026-01-09","kind":"Press release","title":"Jan 9, 2026 Press Releases AirNexis Launches with 200 Million Series A to Advance AN01 AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group","source":"businesswire.com","url":"https://businesswire.com/news/home/20260109716906/en/AirNexis-Therapeutics-Launches-with-$200M-Series-A-to-Advance-Phase-2-Dual-PDE34-Inhibitor-AN01-for-Chronic-Obstructive-Pulmonary-Disease-COPD"},{"date":"2026-01-09","kind":"News","title":"海思科：与AirNexis签署HSK39004项目授权许可协议 _ 东方财富网","source":"finance.eastmoney.com","url":"https://finance.eastmoney.com/a/202601093614531393.html"},{"date":"2026-01-09","kind":"News","title":"海思科与AirNexis签署HSK39004项目授权许可协议 _ 东方财富网","source":"finance.eastmoney.com","url":"https://finance.eastmoney.com/a/202601093614496591.html"},{"date":"2026-01-09","kind":"News","title":"AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)","source":"YahooFinance","url":"https://finance.yahoo.com/news/airnexis-therapeutics-launches-200m-series-130000674.html"}],"as_of":"2026-11-17","cite":"AirNexis, News. Alion, Nov 17, 2026. https://alion.io/company/world-13/news","html_url":"https://alion.io/company/world-13/news","json_url":"https://alion.io/company/world-13/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T21:08:41Z"}}